The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Open accessAbstract
Highly rearranged and mutated cancer genomes present major challenges in the identification of pathogenetic events driving the neoplastic transformation process. Here we engineered lymphoma-prone mice with chromosomal instability to assess the usefulness of mouse models in cancer gene discovery and the extent of cross-species overlap in cancer-associated copy number aberrations. Along with targeted re-sequencing, our comparative oncogenomic studies identified FBXW7 and PTEN to be commonly deleted both in murine lymphomas and in human T-cell acute lymphoblastic leukaemia/lymphoma (T-ALL). The murine cancers acquire widespread recurrent amplifications and deletions targeting loci syntenic to those not only in human T-ALL but also in diverse human haematopoietic, mesenchymal and epithelial tumours. These results indicate that murine and human tumours experience common biological processes driven by orthologous genetic events in their malignant evolution. The highly concordant nature of genomic events encourages the use of genomically unstable murine cancer models in the discovery of biological driver events in the human oncogenome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unlike classical balanced translocations, non-reciprocal translocations lead to copy number changes of the genes residing near the translocation breakage-rearrangement point (105).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Self-citationA census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Self-citationActivating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,706
Self-citationHingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Circular binary segmentation for the analysis of array-based DNA copy number data
Olshen, A. B., Venkatraman, E. S., Lucito, R., & Wigler, M. H. (2004) · Biostatistics · doi:10.1093/biostatistics/kxh008 · Cited by 2,304
Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., & Sklar, J. (1991) · Cell · doi:10.1016/0092-8674(91)90111-b · Cited by 1,691
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain
Schroeter, E. H., Kisslinger, J. A., & Kopan, R. (1998) · Nature · doi:10.1038/30756 · Cited by 1,624
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Self-citationGain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Cited by
Sorted by citations
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Self-citationThe patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Self-citationWelcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Coustan‐Smith, E., Mullighan, C. G., Onciu, M. M., Behm, F. G., Raimondi, S. C., Pei, D., Cheng, C., Su, X., Rubnitz, J. E., Basso, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70314-0 · Cited by 1,012
Mining the plasma proteome for cancer biomarkers
Hanash, S., Pitteri, S. J., & Faça, V. M. (2008) · Nature · doi:10.1038/nature06916 · Cited by 893
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Self-citationp53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., et al. (2008) · Nature · doi:10.1038/nature07443 · Cited by 767
Self-citationTelomere length, stem cells and aging
Blasco, M. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.38 · Cited by 747
Mechanisms and function of substrate recruitment by F-box proteins
Skaar, J. R., Pagan, J. K., & Pagano, M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3582 · Cited by 671
Context is everything: aneuploidy in cancer
Ben‐David, U., & Amon, A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0171-x · Cited by 683
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Inuzuka, H., Shaik, S., Onoyama, I., Gao, D., Tseng, A., Maser, R. S., Zhai, B., Wan, L., Gutiérrez, A., Lau, A. W., et al. (2011) · Nature · doi:10.1038/nature09732 · Cited by 635
Self-citationFernald, K., & Kurokawa, M. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.006 · Cited by 606
Roles of F-box proteins in cancer
Wang, Z. P., Liu, P., Inuzuka, H., & Wei, W. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3700 · Cited by 522
Emerging patterns of somatic mutations in cancer
Watson, I. R., Takahashi, K., Futreal, P. A., & Chin, L. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3539 · Cited by 497
Self-citationda Silva, A. B. G., Yunes, J. A., Cardoso, B. A., Martins, L. R., Jotta, P. Y., Abecasis, M., Nowill, A. E., Leslie, N. R., Cardoso, A. A., & Barata, J. T. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34616 · Cited by 450
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
Gutiérrez, A., Sanda, T., Grebliunaite, R., Carracedo, A., Salmena, L., Ahn, Y., Dahlberg, S. E., Neuberg, D. S., Moreau, L. A., Winter, S. S., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206722 · Cited by 443
Self-citationMolecular pathogenesis of T-cell leukaemia and lymphoma
Aifantis, I., Raetz, E. A., & Buonamici, S. (2008) · Nature reviews. Immunology · doi:10.1038/nri2304 · Cited by 428
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
Zenatti, P. P., Ribeiro, D., Li, W., Zuurbier, L. C., da Silva, M. C., Paganin, M., Tritapoe, J. M., Hixon, J. A., Silveira, A. B., Cardoso, B. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.924 · Cited by 426
Telomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Shi, Q., Xue, C., Zeng, Y., Yuan, X., Chu, Q., Jiang, S., Wang, J., Zhang, Y., Zhu, D., & Li, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01828-x · Cited by 428
Self-citationCheon, D., & Oršulić, S. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.154244 · Cited by 413
Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think
Lobry, C., Oh, P., & Aifantis, I. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20111855 · Cited by 358
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
Scott, K. L., Kabbarah, O., Liang, M., Ivanova, E. V., Anagnostou, V., Wu, J., Dhakal, S., Wu, M., Chen, S., Feinberg, T. Y., et al. (2009) · Nature · doi:10.1038/nature08109 · Cited by 354
Self-citationTumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities
Davis, R. J., Welcker, M., & Clurman, B. E. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.013 · Cited by 343
SCF ubiquitin ligase-targeted therapies
Skaar, J. R., Pagan, J. K., & Pagano, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4432 · Cited by 344
Making sense of cancer genomic dataPreprint
Chin, L., Hahn, W. C., Getz, G. A., & Meyerson, M. M. (2011) · Genes & Development · doi:10.1101/gad.2017311 · Cited by 346
Self-citationNuclear Receptor Coregulators and Human Disease
Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 318
Translating insights from the cancer genome into clinical practice
Chin, L., & Gray, J. W. (2008) · Nature · doi:10.1038/nature06914 · Cited by 304
Self-citationAntitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
HU, J. L., Hwang, S. S., Liesa, M., Gan, B., Sahin, E., Jaskelioff, M., Ding, Z., Ying, H., Boutin, A. T., Zhang, H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.028 · Cited by 308
Self-citationMechanisms of T Cell Development and Transformation
Koch, U., & Radtke, F. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154008 · Cited by 318
Martinelli, P., Pau, E. C. D. S., Cox, T. F., Sáinz, B., Dusetti, N., Greenhalf, W., Rinaldi, L., Costello, E., Ghaneh, P., Malats, N., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311256 · Cited by 273
Ubiquitination and the Regulation of Membrane Proteins
Foot, N. J., Henshall, T. L., & Kumar, S. (2016) · Physiological Reviews · doi:10.1152/physrev.00012.2016 · Cited by 272
A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)
Mavrakis, K. J., der Meulen, J. V., Wolfe, A. L., Liu, X., Mets, E., Taghon, T., Khan, A. A., Setty, M. N., Rondou, P., Vandenberghe, P., et al. (2011) · Nature Genetics · doi:10.1038/ng.858 · Cited by 262
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancerPreprint
Olson, P., Lü, J., Zhang, H., Shai, A., Chun, M. G. H., Wang, Y., Libutti, S. K., Nakakura, E. K., Golub, T. R., & Hanahan, D. (2009) · Genes & Development · doi:10.1101/gad.1820109 · Cited by 270
Self-citationDysfunctional telomeres activate an ATM‐ATR‐dependent DNA damage response to suppress tumorigenesis
Guo, X., Deng, Y., Lin, Y., Cosme‐Blanco, W., Chan, S., He, H., Yuan, G., Brown, E. J., & Chang, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601893 · Cited by 258
A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development
Faça, V. M., Song, K. S., Wang, H., Zhang, Q., Krasnoselsky, A. L., Newcomb, L. F., Plentz, R. R., Gurumurthy, S., Redston, M. S., Pitteri, S. J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050123 · Cited by 255
Self-citationIron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis
Toyokuni, S., Ito, F., Yamashita, K., Okazaki, Y., & Akatsuka, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.024 · Cited by 252
Notch signaling: switching an oncogene to a tumor suppressor
Lobry, C., Oh, P., Mansour, M. R., Look, A. T., & Aifantis, I. (2014) · Blood · doi:10.1182/blood-2013-08-355818 · Cited by 258
Self-citationThrowing the cancer switch: reciprocal roles of polycomb and trithorax proteins
Mills, A. A. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2931 · Cited by 256
Asnafi, V., Buzyn, A., Noir, S. L., Baleydier, F., Simon, A., Beldjord, K., Reman, O., Witz, F., Fagot, T., Tavernier, E., et al. (2008) · Blood · doi:10.1182/blood-2008-10-184069 · Cited by 245
Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
Kelly, K. A., Bardeesy, N. M., Anbazhagan, R., Gurumurthy, S., Berger, J. H., Alencar, H., DePinho, R. A., Mahmood, U., & Weissleder, R. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050085 · Cited by 242
Self-citationMulti-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation
Guo, W., Lasky, J. L., Chang, C.-J., Mosessian, S., Lewis, X., Xiao, Y., Yeh, J., Chen, J. Y., Iruela‐Arispe, M. L., Varella‐Garcia, M., et al. (2008) · Nature · doi:10.1038/nature06933 · Cited by 246
Cell competition is a tumour suppressor mechanism in the thymus
Martins, V. C., Busch, K., Juraeva, D., Blum, C., Ludwig, C., Rasche, V., Lasitschka, F., Mastitsky, S. E., Brors, B., Hielscher, T., et al. (2014) · Nature · doi:10.1038/nature13317 · Cited by 231
The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia
Palomero, T., Domínguez, M., & Ferrando, A. A. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5753 · Cited by 222
Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?
van Staveren, W. C. G., Solís, D. Y. W., Hébrant, A., Detours, V., Dumont, J. E., & Maenhaut, C. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.12.004 · Cited by 231
Ding, Z., Wu, C.-J., Jaskelioff, M., Ivanova, E., Kost-Alimova, M., Protopopov, A., Chu, G. C., Wang, G., Lu, X., Labrot, E. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.039 · Cited by 220
Self-citationTelomere Dynamics in Mice and Humans
Calado, R. T., & Dumitriu, B. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.03.030 · Cited by 214
Genetically Engineered Mouse Models in Cancer Research
Walrath, J. C., Hawes, J. J., Dyke, T. V., & Reilly, K. M. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)06004-5 · Cited by 222
mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization
Gan, B., Sahin, E., Jiang, S., Sánchez‐Aguilera, A., Scott, K. L., Chin, L., Williams, D. A., Kwiatkowski, D. J., & DePinho, R. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810584105 · Cited by 204
Self-citationThe Quest for the 1p36 Tumor Suppressor
Bagchi, A., & Mills, A. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2095 · Cited by 196
McFadden, D. G., Politi, K., Bhutkar, A., Chen, F. K., Song, X., Pirun, M., Santiago, P. M., Kim-Kiselak, C., Platt, J. T., Lee, E., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613601113 · Cited by 194
Kim, J., Hoffman, J. P., Alpaugh, R. K., Rhim, A. D., Reichert, M., Stanger, B. Z., Furth, E. E., Sepulveda, A. R., Yuan, C., Won, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.05.036 · Cited by 198
DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinomaPreprint
Xue, W., Krasnitz, A., Lucito, R., Sordella, R., Aelst, L. V., Cordon‐Cardo, C., Singer, S., Kuehnel, F., Wigler, M. H., Powers, S., et al. (2008) · Genes & Development · doi:10.1101/gad.1672608 · Cited by 188
Etchin, J., Sanda, T., Mansour, M. R., Kentsis, A., Montero, J., Le, B. T., Christie, A. L., McCauley, D., Rodig, S. J., Kauffman, M. G., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12231 · Cited by 182
Self-citationMatsuoka, S., Oike, Y., Onoyama, I., Iwama, A., Arai, F., Takubo, K., Mashimo, Y., Oguro, H., Nitta, E., Ito, K., et al. (2008) · Genes & Development · doi:10.1101/gad.1621808 · Cited by 192
Non-germline genetically engineered mouse models for translational cancer research
Heyer, J., Kwong, L. N., Lowe, S. W., & Chin, L. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2877 · Cited by 181
Self-citationControl of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7
Thompson, B. J., Janković, V., Gao, J., Buonamici, S., Vest, A., Lee, J. M., Zavadil, J., Nimer, S. D., & Aifantis, I. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080277 · Cited by 171
Kwun, H. J., Shuda, M., Feng, H., Camacho, C. J., Moore, P. S., & Chang, Y. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.008 · Cited by 180
Medyouf, H., Gusscott, S., Wang, H., Tseng, J., Wai, C., Nemirovsky, O., Trumpp, A., Pflumio, F., Carboni, J. M., Gottardis, M. M., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110121 · Cited by 167
Self-citationNotch signalling in T‐cell lymphoblastic leukaemia/lymphoma and other haematological malignancies
Aster, J. C., Blacklow, S. C., & Pear, W. S. (2010) · The Journal of Pathology · doi:10.1002/path.2789 · Cited by 167
Self-citationNotch pathway activation targets AML-initiating cell homeostasis and differentiation
Lobry, C., Ntziachristos, P., Ndiaye‐Lobry, D., Oh, P., Cimmino, L., Zhu, N., Araldi, E., Hu, W., Freund, J. E., Abdel-Wahab, O. I., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121484 · Cited by 169
The TLX1 oncogene drives aneuploidy in T cell transformation
Keersmaecker, K. D., Real, P. J., Gatta, G. D., Palomero, T., Sulis, M. L., Tosello, V., Vlierberghe, P. V., Barnes, K., Castillo-Martín, M., Solé, X., et al. (2010) · Nature Medicine · doi:10.1038/nm.2246 · Cited by 158
Self-citationRoderick, J. E., Tesell, J., Shultz, L. D., Brehm, M. A., Greiner, D. L., Harris, M. H., Silverman, L. B., Sallan, S. E., Gutiérrez, A., Look, A. T., et al. (2014) · Blood · doi:10.1182/blood-2013-08-522698 · Cited by 160
Self-citationIFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
Takeda, K., NAKAYAMA, M., Hayakawa, Y., Kojima, Y., Ikeda, H., Imai, N., Ogasawara, K., Okumura, K., Thomas, D. M., & Smyth, M. J. (2017) · Nature Communications · doi:10.1038/ncomms14607 · Cited by 159
Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia
Vlierberghe, P. V., Pieters, R., Beverloo, H. B., & Meijerink, J. P. P. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07314.x · Cited by 166
Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer
Kulasingam, V., Pavlou, M. P., & Diamandis, E. P. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2831 · Cited by 150
Thompson, S. L., & Compton, D. A. (2010) · Chromosome Research · doi:10.1007/s10577-010-9179-y · Cited by 161
‘One medicine—one pathology': are veterinary and human pathology prepared?
Cardiff, R. D., Ward, J. M., & Barthold, S. W. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700695 · Cited by 159
Mullighan, C. G., & Downing, J. R. (2009) · Leukemia · doi:10.1038/leu.2009.18 · Cited by 147
Min, S. H., Lau, A. W., Lee, T. H., Inuzuka, H., Wei, S., Huang, P., Shaik, S., Lee, D. Y., Finn, G., Balaštík, M., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.012 · Cited by 146
Schaetzlein, S., Nalapareddy, K., Ju, Z., Lechel, A., Stępczyńska, A., Lilli, D. R., Clark, A. B., Rudolph, C., Kühnel, F., Wei, K., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.029 · Cited by 146
Dovey, O. M., Foster, C. T., Conte, N., Edwards, S. A., Edwards, J. M., Singh, R., Vassiliou, G. S., Bradley, A., & Cowley, S. M. (2013) · Blood · doi:10.1182/blood-2012-07-441949 · Cited by 143
Buckley, R. M., Davis, B. W., Brashear, W. A., Farias, F. G., Kuroki, K., Graves, T., Hillier, L., Kremitzki, M., Li, G., Middleton, R. P., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008926 · Cited by 145
Targeting the Notch1 and mTOR pathways in a mouse T-ALL model
Cullion, K., Draheim, K., Hermance, N. M., Tammam, J. G., Sharma, V. M., Ware, C. M., Nikov, G. N., Krishnamoorthy, V., Majumder, P. K., & Kelliher, M. A. (2009) · Blood · doi:10.1182/blood-2008-02-136762 · Cited by 144
Mansour, M. R., Sanda, T., Lawton, L. N., Li, X., Kreslavsky, T., Novina, C. D., Brand, M., Gutiérrez, A., Kelliher, M. A., Jamieson, C. H. M., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122516 · Cited by 135
Self-citationHtrA Serine Proteases as Potential Therapeutic Targets in Cancer
CHIEN, J. R., Campioni, M., Shridhar, V., & Baldi, A. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788486704 · Cited by 135
Clappier, E., Collette, S., Grardel, N., Girard, S., Suarez, L., Brunie, G., Kaltenbach, S., Yakouben, K., Mazingue, F., Robert, A., et al. (2010) · Leukemia · doi:10.1038/leu.2010.205 · Cited by 128
Role of telomeres and telomerase in genomic instability, senescence and cancer
Deng, Y., & Chang, S. S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700673 · Cited by 127
Kox, C., Zimmermann, M., Stanulla, M., Leible, S., Schrappe, M., Ludwig, W.-D., Koehler, R., Tolle, G., Bandapalli, O. R., Breit, S., et al. (2010) · Leukemia · doi:10.1038/leu.2010.203 · Cited by 136
Mechanisms of transcription factor deregulation in lymphoid cell transformation
O’Neil, J., & Look, A. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210766 · Cited by 128
Self-citationThe significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia
Zuurbier, L. C., Petricoin, E. F., Vuerhard, M., Calvert, V. S., Kooi, C., Buijs-Gladdines, J. G. C. A. M., Smits, W. K., Sonneveld, E., Veerman, A. J. P., Kamps, W. A., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.059030 · Cited by 122
Inactivation of LEF1 in T-cell acute lymphoblastic leukemia
Gutiérrez, A., Sanda, T., Ma, W., Zhang, J., Grebliunaite, R., Dahlberg, S. E., Neuberg, D. S., Protopopov, A. I., Winter, S. S., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-234377 · Cited by 120
Self-citationVital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia
Lee, K., Nam, K. T., Cho, S. H., Gudapati, P., Hwang, Y., Park, D., Potter, R. M., Chen, J., Volanakis, E. J., & Boothby, M. R. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111470 · Cited by 120
Feedback Circuit among INK4 Tumor Suppressors Constrains Human Glioblastoma Development
Wiedemeyer, R., Brennan, C., Heffernan, T. P., Xiao, Y., Mahoney, J. E., Protopopov, A. I., Zheng, H., Bignell, G. R., Furnari, F. B., Cavenee, W. K., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.010 · Cited by 118
Self-citationFbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver
Onoyama, I., Suzuki, A., Matsumoto, A., Tomita, K., Katagiri, H., Oike, Y., Nakayama, K., & Nakayama, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40725 · Cited by 118
Mansour, M. R., Sulis, M. L., Duke, V. M., Foroni, L., Jenkinson, S., Koo, K., Allen, C. G., Gale, R. E., Buck, G. A. N., Richards, S. M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.0996 · Cited by 115
Self-citationRegulation of cell differentiation by the DNA damage response
Sherman, M. H., Bassing, C. H., & Teitell, M. A. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.01.004 · Cited by 119
The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation
Moran-Crusio, K., King, B., Reavie, L. B., & Aifantis, I. (2010) · Oncogene · doi:10.1038/onc.2010.222 · Cited by 117
The Fbw7 and BetaTRCP E3 ubiquitin ligases and their roles in tumorigenesis
Alan, W. L. (2012) · Frontiers in bioscience · doi:10.2741/4045 · Cited by 112
STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNAPreprint
Chen, A.-J., Paik, J.-H., Zhang, H., Shukla, S. A., Mortensen, R., HU, J. L., Ying, H., Hu, B., Hurt, J. A., Farny, N. G., et al. (2012) · Genes & Development · doi:10.1101/gad.189001.112 · Cited by 116
Self-citationThe Biology of F-box Proteins: The SCF Family of E3 Ubiquitin Ligases
Nguyen, K. M., & Busino, L. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_8 · Cited by 108
Yu, X., Wang, Y., Jiang, M., Bierie, B., Roy‐Burman, P., Shen, M. M., Taketo, M. M., Wills, M. L., & Matusik, R. J. (2008) · The Prostate · doi:10.1002/pros.20877 · Cited by 107
Self-citationRole of the ubiquitin ligase Fbw7 in cancer progression
Cheng, Y., & Li, G. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9330-z · Cited by 105
Mouse Models of Prostate Cancer
Valkenburg, K. C., & Williams, B. O. (2011) · Prostate Cancer · doi:10.1155/2011/895238 · Cited by 114
Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL
Tatarek, J., Cullion, K., Ashworth, T. D., Gerstein, R. M., Aster, J. C., & Kelliher, M. A. (2011) · Blood · doi:10.1182/blood-2010-08-300343 · Cited by 111
Self-citationAkatsuka, S., Yamashita, Y., Ohara, H., Liu, Y.-T., Izumiya, M., Abe, K., Ochiai, M., Jiang, L., Nagai, H., Okazaki, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043403 · Cited by 102
1p36 Tumor Suppression—A Matter of Dosage?
Henrich, K., Schwab, M., & Westermann, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2230 · Cited by 103
Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia
Jotta, P. Y., Ganazza, M., SILVA, A. A. A. D., Viana, M. B., da Silva, M. J., Zambaldi, L. D. J. G., Barata, J. T., Brandalise, S. R., & Yunes, J. A. (2009) · Leukemia · doi:10.1038/leu.2009.209 · Cited by 99
Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1
Li, X., Gounari, F., Protopopov, A. I., Khazaie, K., & von Boehmer, H. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081561 · Cited by 97
Self-citationPrkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice
Molyneux, S. D., Grappa, M. A. D., Beristain, A. G., McKee, T. D., Wai, D., Paderova, J., Kashyap, M., Hu, P., Maiuri, T., Narala, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42391 · Cited by 100
Metadata
- Authors
- Maser, R. S., Choudhury, B., Campbell, P. J., Feng, B., Wong, K.-K., Protopopov, A., O’Neil, J., Gutierrez, A., Ivanova, E., Perna, I., Lin, E., Mani, V., Jiang, S., McNamara, K., Zaghlul, S., Edkins, S., Stevens, C., Brennan, C., Martin, E. S., Wiedemeyer, R., Kabbarah, O., Nogueira, C., Histen, G., Aster, J., Mansour, M., Duke, V., Foroni, L., Fielding, A. K., Goldstone, A. H., Rowe, J. M., Wang, Y. A., Look, A. T., Stratton, M. R., Chin, L., Futreal, P. A., & DePinho, R. A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Wellcome Sanger Institute (GB)
- Agilent Technologies (United States) (US)
- Memorial Sloan Kettering Cancer Center (US)
- The Royal Free Hospital (GB)
- University College London (GB)
- Technion – Israel Institute of Technology (IL)
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Choudhury, Bhudipa
- Campbell, Peter J.
- Feng, Bin
- Wong, Kwok-Kin
- Protopopov, Alexei
- O’Neil, Jennifer
- Ivanova, Elena
- Lin, Eric
- Jiang, Shan
- Edkins, Sarah
- Brennan, Cameron
- Martin, Eric S.
- Kabbarah, Omar
- Nogueira, Cristina
- Aster, Jon
- Mansour, Marc
- Fielding, Adele K.
- Goldstone, Anthony H.
- Rowe, Jacob M.
- Look, A. Thomas
- Stratton, Michael R.
- Futreal, P. Andrew
- DePinho, Ronald A.
- Venue
- Nature
- Published
- 2007-05-21
- Volume
- 447
- Issue
- 7147
- Pages
- 966-971
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2714968
- OpenAlex
- W1982767015
- Cited by
- 377
- References
- 50
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 5 · 2020: 11 · 2019: 6 · 2018: 12 · 2017: 16 · 2016: 17 · 2015: 21 · 2014: 25 · 2013: 34 · 2012: 32
- FWCI
- 15.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- Wellcome Trust (077012, 088340)
- Kay Kendall Leukaemia Fund
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- chromosomal instability, mouse lymphoma model, T-cell acute lymphoblastic lymphoma, FBXW7, PTEN, notches, copy number alterations, genomic instability, driver mutations, tumor evolution, syntenic loci
- MeSH terms
- Animals, Chromosome Aberrations, Humans, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Genome, Conserved Sequence, Synteny, Chromosomal Instability, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
